Software VERIQA (S070031), version 2.0 and 2.1- Software package for display, evaluation and digital processing of medical image data sets and treatment plans in radiation oncology.
Published February 28, 2024 · Recall initiated: February 8, 2024
Summary
FDA records medical device Class II recall Z-1181-2024, published February 28, 2024 and initiated February 8, 2024. Recalling firm: PTW-FREIBURG; Status: Ongoing; Reported quantity: 1 US; 65 worldwide; Lot: UDI-DI: EPTWS070031 Software VERIQA (S070031), version 2.0 and 2.1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Software: If the user excludes voxels from the Gamma calculation that are below a dose threshold (Suppress gamma calculation), the Gamma Passing Rate (GPR) calculated for individual ROIs is not correct. The GPR calculated by VERIQA overestimates the correct GPR. The evaluation can therefore show false positive results.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- PTW-FREIBURG
- Distributor
- GA
- Lot
- UDI-DI: EPTWS070031 Software VERIQA (S070031), version 2.0 and 2.1
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Germany
Related recalls
- FDAFluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only,March 6, 2024
- FDAMesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: SunMarch 6, 2024
- FDAEquate Lubricant Eye Ointment (Mineral Oil 42.5%, White Petrolatum 57.3%), Packaged in 3.5 gram tubes,March 6, 2024
- FDAThese wipes are saturated with 0.65% bleach solution. These wipes are antimicrobial, disinfectant withFebruary 28, 2024
- FDAGORE VIABIL Short Wire Biliary Endoprosthesis, Product labeled as (1) Catalog Number VSWVH1008, 10 mm x 8 cm;February 28, 2024
- FDAAzurion 7 with a Certeray generator-To perform image guidance in diagnostic, interventional, and minimallyFebruary 28, 2024
Questions about this recall
Was Software VERIQA (S070031), version 2.0 and 2.1- Software package for display, evaluation and digital processing of medical image data sets and treatment plans in radiation oncology. recalled?
Yes. FDA published recall Z-1181-2024 on February 28, 2024. Reported hazard: Software: If the user excludes voxels from the Gamma calculation that are below a dose threshold (Suppress gamma calculation), the Gamma Passing Rate (GPR) calculated for individual ROIs is not correct. The GPR calculated by VERIQA overestimates the correct GPR. The evaluation can therefore show false positive results.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail